Empty mast cell syndrome: fallacy or fact?

Area of Science:

• Immunology
• Allergy
• Dermatology

Background:

• Post-anaphylaxis mast cell anergy (PAMA), or 'empty mast cell syndrome', is a transient state of reduced mast cell reactivity after anaphylaxis.
• PAMA incidence and molecular mechanisms remain largely unknown, with limited case reports in venom allergy and perioperative anaphylaxis.
• Current guidelines suggest allergy work-up 4-6 weeks post-anaphylaxis to avoid false-negative skin tests, based primarily on expert opinion.

Purpose of the Study:

• To review existing clinical literature on PAMA.
• To critically evaluate in vitro data on intracellular mast cell events.
• To hypothesize potential immune mechanisms underlying PAMA.

Main Methods:

• Literature review of clinical case reports and in vitro studies.
• Critical evaluation of intracellular signaling pathways in mast cells.
• Hypothesizing immune mechanisms based on current understanding.

Main Results:

• No direct data explain PAMA's molecular basis.
• Plausible mechanisms include mast cell granule depletion, shift towards inhibitory signaling, FcεRI downregulation, FcεRI/IgG receptor cross-linking, and pharmacotherapeutic effects.
• A combination of proposed mechanisms and unidentified genetic/host factors likely contribute to PAMA.

Conclusions:

• PAMA is a recognized but poorly understood condition affecting mast cell responsiveness post-anaphylaxis.
• Further research is crucial to elucidate the molecular mechanisms and establish evidence-based guidelines for allergy testing.
• Understanding PAMA may improve diagnostic accuracy and patient management following severe allergic reactions.